Lianjia Leo Ma
Associate Scientific Director, CMC Analytical Team Lead Bristol Myers Squibb
Seminars
Wednesday 5th November 2025
Exploring In-Process Control Strategy for Drug- Linker Synthesis & Conjugation Process Development
12:00 pm
• Leveraging multiple analytical tools to understand and define optimal conjugation process
• Using analytical tools to understand and define the end of reduction, conjugation, and TFF purification process operations
• Utilizing purging data of small molecule impurities during development to justify the release/stability specification of final ADC drug substance
